**Core Concept**
Sclerotherapy is a medical procedure that involves the injection of a sclerosing agent into small blood vessels or lymphatic vessels to treat conditions such as varicose veins, spider veins, or lymphedema. The sclerosing agent causes inflammation and damage to the vessel wall, leading to its eventual closure.

**Why the Correct Answer is Right**
The ideal candidate for sclerotherapy is a patient with varicose veins or spider veins that are less than 1 cm in diameter. The sclerosing agent, such as sodium tetradecyl sulfate or polidocanol, is injected into the affected vessel under ultrasound guidance to minimize the risk of complications. The sclerosing agent causes endothelial damage and activation of the coagulation cascade, leading to thrombosis and eventual vessel closure.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because patients with large varicose veins (>1 cm in diameter) are not ideal candidates for sclerotherapy, as they require more invasive treatments such as vein stripping or endovenous laser ablation.

**Option B:** This option is incorrect because patients with deep vein thrombosis (DVT) are not suitable for sclerotherapy, as it may worsen the condition and increase the risk of pulmonary embolism.

**Option C:** This option is incorrect because patients with active infections or inflammation in the affected area are not ideal candidates for sclerotherapy, as it may exacerbate the condition and lead to further complications.

**Clinical Pearl / High-Yield Fact**
It is essential to select the appropriate sclerosing agent and technique based on the patient's underlying condition and vessel size to minimize the risk of complications and ensure optimal outcomes.

**Correct Answer:** D